Bristol Has “Critical Mass” In R&D And Sales; Faces Tough 2004
Bristol-Myers Squibb believes it has the "critical mass" in R&D and sales to continue as a stand-alone company, CEO Peter Dolan said Jan. 29 during the company's year end earnings call
Bristol-Myers Squibb believes it has the "critical mass" in R&D and sales to continue as a stand-alone company, CEO Peter Dolan said Jan. 29 during the company's year end earnings call